Symrise (FRA:SY1 – Get Rating) received a €102.00 ($107.37) price objective from equities research analysts at Warburg Research in a research report issued to clients and investors on Tuesday, Borsen Zeitung reports. Warburg Research’s price target points to a potential upside of 3.66% from the stock’s previous close.
A number of other equities analysts have also recently commented on the company. Credit Suisse Group set a €117.00 ($123.16) target price on Symrise in a report on Wednesday, March 9th. Barclays set a €113.00 ($118.95) target price on Symrise in a report on Wednesday, March 2nd. Berenberg Bank set a €119.00 ($125.26) target price on Symrise in a report on Thursday, March 24th. Baader Bank set a €125.00 ($131.58) target price on Symrise in a report on Friday, April 8th. Finally, Deutsche Bank Rese… set a €138.00 ($145.26) target price on Symrise in a report on Thursday, April 28th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of €120.70 ($127.05).
FRA SY1 traded down €10.95 ($11.53) during trading on Tuesday, hitting €98.40 ($103.58). 393,797 shares of the stock traded hands. The firm has a 50-day simple moving average of €107.45 and a 200-day simple moving average of €114.85. Symrise has a 12-month low of €56.96 ($59.96) and a 12-month high of €73.48 ($77.35).
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Follow The Money To Cigna
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.